Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Parkinson's Disease

Free Subscription 25.02.2019 1 Ann Neurol 1 Biochemistry 1 Exp Neurol 1 J Clin Pharmacol 1 J Neurosci 5 Mov Disord 2 Nat Rev Neurol 1 Neuropsychology 3 Neurosci Lett 1 Neuroscience

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Ann Neurol

1. GOLDMAN SM, Marek K, Ottman R, Meng C, et al
   Concordance for Parkinson's Disease in Twins: a 20-Year Update.
   Ann Neurol. 2019 Feb 20. doi: 10.1002/ana.25441.
   PubMed     Text format     Abstract available
   
   

   
   Biochemistry

2. PAN B, Petersson EJ
   A PARP-1 Feed-Forward Mechanism To Accelerate alpha-Synuclein Toxicity in Parkinson's Disease.
   Biochemistry. 2019;58:859-860.
   PubMed     Text format    
   
   

   
   Exp Neurol

3. DOMENICI RA, Campos ACP, Maciel ST, Berzuino MB, et al
   Parkinson's disease and pain: Modulation of nociceptive circuitry in a rat model of nigrostriatal lesion.
   Exp Neurol. 2019;315:72-81.
   PubMed     Text format     Abstract available
   
   

   
   J Clin Pharmacol

4. DAMASCENO DOS SANTOS EU, Duarte EBC, Miranda LMR, Asano AGC, et al
   Pharmacogenetic Profile and the Occurrence of Visual Hallucinations in Patients With Sporadic Parkinson's Disease.
   J Clin Pharmacol. 2019 Feb 22. doi: 10.1002/jcph.1394.
   PubMed     Text format     Abstract available
   
   

   
   J Neurosci

5. VIANA MAGNO LA, Tenza-Ferrer H, Collodetti M, Felipe Guimaraes Aguiar M, et al
   Optogenetic stimulation of the M2 cortex reverts motor dysfunction in a mouse model of Parkinson's Disease.
   J Neurosci. 2019 Feb 19. pii: JNEUROSCI.2277-18.2019.
   PubMed     Text format     Abstract available
   
   

   
   Mov Disord

6. HENDERSHOTT TR, Zhu D, Llanes S, Zabetian CP, et al
   Comparative sensitivity of the MoCA and Mattis Dementia Rating Scale-2 in Parkinson's disease.
   Mov Disord. 2019;34:285-291.
   PubMed     Text format     Abstract available
   
   
7. ALCALAY RN, Mallett V, Vanderperre B, Tavassoly O, et al
   SMPD1 mutations, activity, and alpha-synuclein accumulation in Parkinson's disease.
   Mov Disord. 2019 Feb 20. doi: 10.1002/mds.27642.
   PubMed     Text format     Abstract available
   
   
8. LIN CH, Chen PL, Tai CH, Lin HI, et al
   A clinical and genetic study of early-onset and familial parkinsonism in taiwan: An integrated approach combining gene dosage analysis and next-generation sequencing.
   Mov Disord. 2019 Feb 20. doi: 10.1002/mds.27633.
   PubMed     Text format     Abstract available
   
   
9. IKEDA A, Shimada H, Nishioka K, Takanashi M, et al
   Clinical heterogeneity of frontotemporal dementia and Parkinsonism linked to chromosome 17 caused by MAPT N279K mutation in relation to tau positron emission tomography features.
   Mov Disord. 2019 Feb 17. doi: 10.1002/mds.27623.
   PubMed     Text format     Abstract available
   
   
10. FANCIULLI A, Goebel G, Lazzeri G, Scherfler C, et al
    Early distinction of Parkinson-variant multiple system atrophy from Parkinson's disease.
    Mov Disord. 2019 Feb 20. doi: 10.1002/mds.27635.
    PubMed     Text format    
    
    

    
    Nat Rev Neurol

11. ESPAY AJ, Marras C
    Clinical Parkinson disease subtyping does not predict pathology.
    Nat Rev Neurol. 2019 Feb 20. pii: 10.1038/s41582-019-0153.
    PubMed     Text format    
    
    
12. LIMOUSIN P, Foltynie T
    Long-term outcomes of deep brain stimulation in Parkinson disease.
    Nat Rev Neurol. 2019 Feb 18. pii: 10.1038/s41582-019-0145.
    PubMed     Text format     Abstract available
    
    

    
    Neuropsychology

13. JOHARI K, Walenski M, Reifegerste J, Ashrafi F, et al
    Sex, dopamine, and hypokinesia: A study of inflectional morphology in Parkinson's disease.
    Neuropsychology. 2019 Feb 18. pii: 2019-08240-001. doi: 10.1037/neu0000533.
    PubMed     Text format     Abstract available
    
    

    
    Neurosci Lett

14. KUMARI N, Agrawal S, Kumari R, Sharma D, et al
    Neuroprotective effect of IDPU (1-(7-imino-3-propyl-2,3-dihydrothiazolo [4,5-d]pyrimidin-6(7H)-yl)urea) in 6-OHDA induced rodent model of hemiparkinson's disease.
    Neurosci Lett. 2018;675:74-82.
    PubMed     Text format     Abstract available
    
    
15. PUPYSHEV AB, Korolenko TA, Akopyan AA, Amstislavskaya TG, et al
    Suppression of autophagy in the brain of transgenic mice with overexpression of capital A, Cyrillic53capital TE, Cyrillic-mutant alpha-synuclein as an early event at synucleinopathy progression.
    Neurosci Lett. 2018;672:140-144.
    PubMed     Text format     Abstract available
    
    
16. ZHANG S, Chen S, Liu A, Wan J, et al
    Inhibition of BDNF production by MPP(+) through up-regulation of miR-210-3p contributes to dopaminergic neuron damage in MPTP model.
    Neurosci Lett. 2018;675:133-139.
    PubMed     Text format     Abstract available
    
    

    
    Neuroscience

17. HAIYANZHANG, Yang J, Xiang T, Sun S, et al
    State-Dependent Spike and Local Field Synchronization between the Thalamic Parafascicular Nucleus and the Dorsal Striatum in a Rat Model of Parkinson's Disease.
    Neuroscience. 2019 Feb 18. pii: S0306-4522(19)30082.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: